Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Odin

Showing results (31-40 of 170) with videos related to

Pageof 17
Sort By:
Journal of Neurology|March 28, 2025
The association between non-motor symptoms and cost in Parkinson's diseaseAnna Gustafsson, Frida Hjalte, Jenny Norlin, et al.
Journal of Parkinson'S Disease|June 23, 2026
Agreement between relatives of Parkinson's patients and clinical observer in home diary assessmentsCarin Janz, Jonathan Timpka, Alexander Storch, et al.
International Review of Neurobiology|May 31, 2017
Device-Aided Treatment Strategies in Advanced Parkinson's DiseaseJonathan Timpka, Bianca Nitu, Veronika Datieva, et al.
Parkinsonism & Related Disorders|July 30, 2025
Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic reviewMichela Garon, Monica Scharfenort, Angelo Antonini, et al.
Journal of Parkinson'S Disease|December 26, 2018
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's DiseaseDaniel J van Wamelen, Sotirios Grigoriou, K Ray Chaudhuri, et al.
NPJ Parkinson'S Disease|May 8, 2023
Time to workforce exit after a Parkinson's disease diagnosisJonathan Timpka, Örjan Dahlström, Maria H Nilsson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 5, 2024
Monotherapy with infusion therapies - useful or not?Petra Bago Rožanković, Anders Johansson, Klivényi Péter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groupsMirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Neuro-Degenerative Diseases|November 1, 2023
A Paradigm Shift in the Management of Patients with Parkinson's DiseaseKonstantinos I Tsamis, Per Odin, Angelo Antonini, et al.
Brain and Behavior|July 11, 2023
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatmentGustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, et al.
Pageof 17

Showing results (31-40 of 170) with videos related to

Sort By:
Pageof 17
Journal of Neurology|March 28, 2025
The association between non-motor symptoms and cost in Parkinson's diseaseAnna Gustafsson, Frida Hjalte, Jenny Norlin, et al.
Journal of Parkinson'S Disease|June 23, 2026
Agreement between relatives of Parkinson's patients and clinical observer in home diary assessmentsCarin Janz, Jonathan Timpka, Alexander Storch, et al.
International Review of Neurobiology|May 31, 2017
Device-Aided Treatment Strategies in Advanced Parkinson's DiseaseJonathan Timpka, Bianca Nitu, Veronika Datieva, et al.
Parkinsonism & Related Disorders|July 30, 2025
Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic reviewMichela Garon, Monica Scharfenort, Angelo Antonini, et al.
Journal of Parkinson'S Disease|December 26, 2018
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's DiseaseDaniel J van Wamelen, Sotirios Grigoriou, K Ray Chaudhuri, et al.
NPJ Parkinson'S Disease|May 8, 2023
Time to workforce exit after a Parkinson's disease diagnosisJonathan Timpka, Örjan Dahlström, Maria H Nilsson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 5, 2024
Monotherapy with infusion therapies - useful or not?Petra Bago Rožanković, Anders Johansson, Klivényi Péter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groupsMirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Neuro-Degenerative Diseases|November 1, 2023
A Paradigm Shift in the Management of Patients with Parkinson's DiseaseKonstantinos I Tsamis, Per Odin, Angelo Antonini, et al.
Brain and Behavior|July 11, 2023
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatmentGustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, et al.
Pageof 17